Stimvia Expands Scientific Advisory Board and Commercial Leadership to Advance Global Market Expansion of Flagship URIS® Therapy

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

STIMVIA-exec-expand

More Like This

PR Newswire associated0

Potential Add-on Treatment for Patients with Parkinson's Disease: Stimvia Completes Pilot Study and Announces Promising Initial Results

PR Newswire associated0

UroMems Receives Clearance from the FDA and the French ANSM for Initiating Landmark Pivotal Clinical Study of UroActive® Smart Implant to Treat Male Stress Urinary Incontinence

PR Newswire associated0

UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clinical Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence

PR Newswire associated0

UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors

PR Newswire associated0

UroMems Reaches Significant Milestone: Successful Results in Clinical Feasibility Study of UroActive™ Smart Implant for Stress Urinary Incontinence Treatment

UroMems Welcomes Medical Device Technology Leader Dan Rose as New Board Chairman

PR Newswire associated0

UroMems Announces Successful Results in First-Ever Female Clinical Feasibility Study of UroActive® Smart Implant for Stress Urinary Incontinence Treatment

ACCESSWIRE logo

UroViu Corporation Appoints Ali Amiri as New President and Chief Operating Officer